Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses

References

• Roglic G. WHO Global report on diabetes: a summary. Int J Noncommunicable Dis. 2016;1(1):3.
   Google Scholar
• International Monetary Fund (IMF). Real GDP growth. 2019 09/December/2019]; Available from: https://www.imf.org/external/datamapper/NGDP_RPCH@WEO/DA.
   Google Scholar
• International Diabetes Federation. IDF Diabetes Atlas Ninth Edition 2019. Available at:https://www.diabetesatlas.org/upload/resources/2019/IDF_Atlas_9th_Edition_2019.pdf Accessed on: 10/10/2019
   Google Scholar
• Esterson YB, Carey M, Piette JD, et al.. A systematic review of innovative diabetes care models in low-and middle-income countries (LMICs). J Health Care Poor Underserved. 2014;25(1):72–93. DOI:10.1353/hpu.2014.0037.
   PubMed Web of Science ®Google Scholar
• Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34(6):1249–1257.
   PubMed Web of Science ®Google Scholar
• Zhang P, Zhang X, Brown J, et al.. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(3):293–301. DOI:10.1016/j.diabres.2010.01.026.
   PubMed Web of Science ®Google Scholar
• Tacconelli E. Systematic reviews: CRD’s guidance for undertaking reviews in health care. Lancet Infect Dis. 2010;10(4):226.
   Google Scholar
• Dedov II, Shestakova MV, Galstyan GR. The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study). Diabetes Mellitus. 2016;19(2):104–112.
   Web of Science ®Google Scholar
• Al-Daghri NM, Al-Attas OS, Alokail MS, et al.. Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med. 2011;9(1):76. DOI:10.1186/1741-7015-9-76.
   PubMed Web of Science ®Google Scholar
• Sharma M, Nazareth I, Petersen I. Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study. BMJ Open. 2016 Jan 1;6(1):e010210.
   Web of Science ®Google Scholar
• Soriguer FEA, Goday A, Bosch-Comas A. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the [email protected] Study. Diabetologia. 2011;55(1):88–93.
   PubMed Web of Science ®Google Scholar
• Sante Publique France. Prevalence and incidence of diabetes. [ cited 2019 January]; Available from: http://invs.santepubliquefrance.fr/Dossiers-thematiques/Maladies-chroniques-et-traumatismes/Diabete/Donnees-epidemiologiques/Prevalence-et-incidence-du-diabete. Accessed: 10/10/2019
   Google Scholar
• Holden SE, Jenkins-Jones S, Morgan CL, et al.. Prevalence, glucose control and relative survival of people with Type 2 diabetes in the UK from 1991 to 2013. Diabet Med. 2017;34(6):770–780. DOI:10.1111/dme.13332.
   PubMed Web of Science ®Google Scholar
• Zghebi SS, Steinke DT, Carr MJ, et al.. Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014. Diabetes Obesity Metab. 2017;19(11):1537–1545. DOI:10.1111/dom.12964.
   PubMed Web of Science ®Google Scholar
• de Almeida-pititto B, Dias ML, de Moraes ACF, et al. Type 2 diabetes in Brazil: epidemiology and management. Diabetes Metab Syndr Obes. 2015;8:17–28.
   PubMed Web of Science ®Google Scholar
• Brown K, Nevitte A, Szeto B, et al.. Growing social inequality in the prevalence of type 2 diabetes in Canada, 2004-2012. Can J Public Health = Revue canadienne de santé publique. 2015;106(3):e132–e139. DOI:10.17269/CJPH.106.4769.
   PubMed Web of Science ®Google Scholar
• Iser BPM, Malta DC, Duncan BB, et al.. Prevalence, correlates, and description of self-reported diabetes in brazilian capitals–results from a telephone survey. PLoS One. 2014;9(9):e108044. DOI:10.1371/journal.pone.0108044.
   PubMed Web of Science ®Google Scholar
• Zhou M, Astell-Burt T, Bi Y, et al.. Geographical variation in diabetes prevalence and detection in China: multilevel spatial analysis of 98,058 adults. Diabetes Care. 38(1): 72–81. 2015. . doi:10.2337/dc14-1100.
   PubMed Web of Science ®Google Scholar
• Canadian Diabetes Association. Prevalence of Diabates in Canada. 2011; Available from: https://www.diabetes.ca/CDA/media/documents/publications-and-newsletters/advocacy-reports/canada-at-the-tipping-point-english.pdf. Accessed: 10/10/2019
   Google Scholar
• Nicolucci A., Rossi C., Lucisano G. Facts and figures about diabetes in Italy: report. Italian Diabetes Monitor. 2014; Available from: http://www.ibdo.it/pdf/DiabetesMonitor-FactandFigure2014.pdfAccessed: 10/10/2019. .
   Google Scholar
• Satman I, Omer B, Tutuncu Y, et al.. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 28(2): 169–180. 2013. . doi:10.1007/s10654-013-9771-5.
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M. Prevalence and control of diabetes in Chinese adults. Jama. 2013;310(9):948–959. DOI:10.1001/jama.2013.168118.
   PubMed Web of Science ®Google Scholar
• Ye RU, Yan QH, XU JY, Di Yang Q, Yao HH, Rui LI, Yan SH. Epidemiology of diabetes in adults aged 35 and older from Shanghai, China. Biomed Environ Sci. 2016;29(6):408–416. DOI:10.3967/bes2016.053.
   PubMed Web of Science ®Google Scholar
• Al‐Rubeaan K, Al‐Manaa HA, Khoja TA, Ahmad NA, Al‐Sharqawi AH, Siddiqui K, Alnaqeb D, Aburisheh KH, Youssef AM, Al‐Batel A, Alotaibi MS. Epidemiology of abnormal glucose metabolism in a country facing its epidemic: SAUDI‐DM study. J Diabetes. 2015;7(5):622–632. DOI:10.1111/1753-0407.12224.
   PubMed Web of Science ®Google Scholar
• Cao Y, Liu YH, Zhang F, et al.. Prevalence of diabetes in adults in Hebei province. Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi. 2016;37(9):1196–1201. DOI:10.3760/cma.j.issn.0254-6450.2016.09.003.
   PubMedGoogle Scholar
• Costa AF, Flor LS, Campos MR, Oliveira AF, Costa MD, Silva RS, Lobato LC, Schramm JM. Burden of type 2 diabetes mellitus in Brazil. Cad Saude Publica. 2017;33(2):684–690. DOI:10.1590/0102-311x00197915.
   Web of Science ®Google Scholar
• Wang L, Gao P, Zhang M, et al.. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. Jama. 2017;317(24):2515–2523. DOI:10.1001/jama.2017.7596.
   PubMed Web of Science ®Google Scholar
• Wang C, Li J, Xue H, Li Y, Huang J, Mai J, Chen J, Cao J, Wu X, Guo D, Yu L. Type 2 diabetes mellitus incidence in Chinese: contributions of overweight and obesity. Diabetes Res Clin Pract. 2015;107(3):424–432. DOI:10.1016/j.diabres.2014.09.059.
   PubMed Web of Science ®Google Scholar
• Republic of the Philippines Department of health. Mortality Statistics. 2013 11/October/2019]; Available from: https://www.doh.gov.ph/mortality.
   Google Scholar
• Soria ML, Sy RG, Vega BS, Ty-Willing T, Abenir-Gallardo A, Velandria F, Punzalan FE. The incidence of type 2 diabetes mellitus in the Philippines: a 9-year cohort study. Diabetes Res Clin Pract. 2009;86(2):130–133.
   PubMed Web of Science ®Google Scholar
• Institute, F.a.N.R., 8th National Nutrition Survey: Food and Nutrition Research Institute. 2014
   Google Scholar
• Onat A, Hergenç G, Uyarel H, et al.. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. Anadolu Kardiyol Derg. 2006;6(4):314–321.
   PubMedGoogle Scholar
• Saadi H, Carruthers SG, Nagelkerke N, et al.. Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates. Diabetes Res Clin Pract. 2007;78(3):369–377. DOI:10.1016/j.diabres.2007.04.008.
   PubMed Web of Science ®Google Scholar
• Ross NA, Gilmour H, Dasgupta K. 14-year diabetes incidence: the role of socio-economic status. Health Rep. 2010;21(3):19.
   PubMed Web of Science ®Google Scholar
• Govenrment of Canada. Chapter 1: Diabetes in Canada: Facts and figures from a public health perspective – Burden. 2011 11/October/2019]; Available from: https://www.canada.ca/en/public-health/services/chronic-diseases/reports-publications/diabetes/diabetes-canada-facts-figures-a-public-health-perspective/chapter-1.html#Inc1.
   Google Scholar
• Sistema statistico nazionale, Annuario statistico italiano 2013. 2013.
   Google Scholar
• Read SH, Kerssens JJ, McAllister DA, et al.. Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013. Diabetologia. 2016;59(10):2106–2113. DOI:10.1007/s00125-016-4054-9.
   PubMed Web of Science ®Google Scholar
• Liu X, Li Y, Li L, et al.. Prevalence, awareness, treatment, control of type 2 diabetes mellitus and risk factors in Chinese rural population: the RuralDiab study. Sci Rep. 2016;6(1):31426. DOI:10.1038/srep31426.
   PubMed Web of Science ®Google Scholar
• Liu X, Wang L, Wang P, et al.. The dynamics of type 2 diabetes mellitus prevalence and management rates among rural population in Henan Province, China. J Diabetes Res. 2017 2017;2017: 1–9.doi: 10.1155/2017/9092759
   Web of Science ®Google Scholar
• Qi L, Feng L, Ding X, et al.. Prevalence of diabetes and impaired fasting glucose among residents in the Three Gorges Reservoir Region, China. BMC Public Health. 2014;14(1):1152. DOI:10.1186/1471-2458-14-1152.
   PubMed Web of Science ®Google Scholar
• Zhou X, Guan H, Zheng L, et al.. Prevalence and awareness of diabetes mellitus among a rural population in China: results from Liaoning Province. Diabetic Med. 2015;32(3):332–342. DOI:10.1111/dme.12599.
   PubMed Web of Science ®Google Scholar
• Jimeno CA, Kho SA, Matawaran BJ, Duante CA, Jasul GV. Prevalence of diabetes mellitus and pre-diabetes in the Philippines: a sub-study of the 7th National Nutrition and Health Survey (2008). Philipp J Int Med. 2015;53(2):1–8.
   Google Scholar
• Jiang Y-D, Chang C-H, Tai T-Y, et al.. Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000–2009 Nationwide Health Insurance database. J Formosan Med Assoc. 111(11): 599–604. 2012. . doi:10.1016/j.jfma.2012.09.014.
   PubMed Web of Science ®Google Scholar
• Moody A, Cowley G, Ng Fat L, et al.. Social inequalities in prevalence of diagnosed and undiagnosed diabetes and impaired glucose regulation in participants in the Health Surveys for England series. BMJ Open. 6(2): e010155. 2016. . doi:10.1136/bmjopen-2015-010155.
   PubMed Web of Science ®Google Scholar
• Australia Institute of Health and Welfare. Diabetes snapshot. 2017-2018 [ cited 2019 January]; Available from: https://www.aihw.gov.au/reports/diabetes/diabetes-snapshot/data.
   Google Scholar
• Du Y, Heidemann C, Gößwald A, et al.. Prevalence and comorbidity of diabetes mellitus among non-institutionalized older adults in Germany-results of the national telephone health interview survey ‘German Health Update (GEDA)’2009. BMC Public Health. 2013;13(1):166. DOI:10.1186/1471-2458-13-166.
   PubMed Web of Science ®Google Scholar
• Tamayo T, Brinks R, Hoyer A, Kuß O, Rathmann W.  The prevalence and incidence of diabetes in Germany: an analysis of statutory health insurance data on 65 million individuals from the years 2009 and 2010. Dtsch Arztebl Int. 2016;113(11):177.
   PubMed Web of Science ®Google Scholar
• Heidemann C, Du Y, Paprott R, et al.. Temporal changes in the prevalence of diagnosed diabetes, undiagnosed diabetes and prediabetes: findings from the German Health Interview and Examination Surveys in 1997–1999 and 2008–2011. Diabetic Med. 2016;33(10):1406–1414. DOI:10.1111/dme.13008.
   PubMed Web of Science ®Google Scholar
• Societa Italiana di Diabetologia. Il diabete in Italia. Societa Italian di Diabetologia. 2016; Available from: http://www.siditalia.it/pdf/Il%20Diabete%20in%20Italia_p.pdfAccessed: 10/10/2019.
   Google Scholar
• Onat A, et al.. Turkish adult risk factor survey 2013: rapid rise in the prevalence of diabetes. Turk Kardiyoloji Dernegi Arsivi. 2014;42(6):511–516. DOI:10.5543/tkda.2014.27543.
   PubMedGoogle Scholar
• International Diabetes Federation. IDF Diabetes Atlas Eighth Edition 2017. Available at: http://fmdiabetes.org/wp-content/uploads/2018/03/IDF-2017.pdf Accessed on: 10/10/2019.
   Google Scholar
• Wilke T, Ahrendt P, Schwartz D, Linder R, Ahrens S, Verheyen F. Incidence and prevalence of type 2 diabetes mellitus in Germany: an analysis based on 5.43 million patients. Dtsch Med Wochenschr. (1946), 2013;138(3):69–75.
   Google Scholar
• Sreedharan J, Muttappallymyalil J, Al Sharbatti S, et al.. Incidence of Type 2 Diabetes Mellitus among Emirati Residents in Ajman, United Arab Emirates. Korean J Fam Med. 2015;36(5):253–257. DOI:10.4082/kjfm.2015.36.5.253.
   PubMed Web of Science ®Google Scholar
• Lin WH, Hsu C-H, Chen H-F, et al.. Mortality of patients with type 2 diabetes in Taiwan: a 10-year nationwide follow-up study. Diabetes Res Clin Pract. 2015;107(1):178–186. DOI:10.1016/j.diabres.2014.09.021.
   PubMed Web of Science ®Google Scholar
• Dedov II, Shestakova MV, Vikulova OK. and Olga Konstantinovna Vikulova., Epidemiology of diabetes mellitus in Russian Federation: clinical and statistical report according to the federal diabetes registry. Diabetes Mellitus. 2017;20(1):13–41.
   Web of Science ®Google Scholar
• Statistics Canada. Mortality from diabetes mellitus, 2004 to 2008: a multiple-cause-of-death analysis. 2015 11/October/2019]; Available from: https://www150.statcan.gc.ca/n1/pub/82-003-x/2014003/article/11909-eng.htm.
   Google Scholar
• Orozco-Beltrán D, Sánchez E, Garrido A, et al.. Evolución de la mortalidad por diabetes mellitus en España: análisis del periodo 1998-2013. Revista Española de Cardiología. 2017;70(6):433–443. DOI:10.1016/j.recesp.2016.07.007.
   PubMed Web of Science ®Google Scholar
• Jacobs E, Hoyer A, Brinks R, et al.. Burden of Mortality Attributable to Diagnosed Diabetes: a nationwide analysis based on claims data from 65 million people in Germany. Diabetes Care. 2017;40(12):1703–1709. DOI:10.2337/dc17-0954.
   PubMed Web of Science ®Google Scholar
• Harding JL, Shaw JE, Peeters A, et al.. Age-specific trends from 2000–2011 in all-cause and cause-specific mortality in type 1 and type 2 diabetes: a cohort study of more than one million people. Diabetes Care. 2016;39(6):1018–1026. DOI:10.2337/dc15-2308.
   PubMed Web of Science ®Google Scholar
• Monesi L, Baviera M, Marzona I, et al.. Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian population‐based study. Diabetic Med. 2012;29(3):385–392. DOI:10.1111/j.1464-5491.2011.03446.x.
   PubMed Web of Science ®Google Scholar
• Liu X, Yu C, Wang Y, et al.. Trends in the Incidence and Mortality of Diabetes in China from 1990 to 2017: a joinpoint and age-period-cohort analysis. Int J Environ Res Public Health. 16(1): 158. 2019. . doi:10.3390/ijerph16010158.
   PubMed Web of Science ®Google Scholar
• Mandereau-Bruno, L., Fagot-Campagna, A., Rey, G., Piffaretti, C., Antero-Jacquemin, J. and Latouche, A. Évolution de la mortalité et de la surmortalité à 5 ans des personnes diabétiques traitées pharmacologiquement en France métropolitaine: comparaison des cohortes Entred 2001 et Entred 2007. Bull Epidémiol Hebd. 2016;37–38.
   Google Scholar
• Kostev K, Jockwig A, Hallwachs A, et al.. Prevalence and risk factors of neuropathy in newly diagnosed type 2 diabetes in primary care practices: a retrospective database analysis in Germany and UK. Prim Care Diabetes. 2014;8(3):250–255. DOI:10.1016/j.pcd.2014.01.011.
   PubMed Web of Science ®Google Scholar
• Pan C-W, Wang S, Qian D-J, et al.. Prevalence, awareness, and risk factors of diabetic retinopathy among adults with known type 2 diabetes mellitus in an Urban Community in China. Ophthalmic Epidemiol. 2017;24(3):188–194. DOI:10.1080/09286586.2016.1264612.
   PubMed Web of Science ®Google Scholar
• Xu J, Wei WB, Yuan MX, et al.. Prevalence and risk factors for diabetic retinopathy: the Beijing communities diabetes study 6. Retina. 2012;32(2):322–329. DOI:10.1097/IAE.0b013e31821c4252.
   PubMed Web of Science ®Google Scholar
• Al-Rubeaan K, Abu El-Asrar AM, Youssef AM, et al.. Diabetic retinopathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study. Acta Ophthalmol. 2015;93(2):e140–7. DOI:10.1111/aos.12532.
   PubMed Web of Science ®Google Scholar
• Salvotelli L, Stoico V, Perrone F, et al.. Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: the Verona diabetic foot screening program. J Diabetes Complications. 2015;29(8):1066–1070. DOI:10.1016/j.jdiacomp.2015.06.014.
   PubMed Web of Science ®Google Scholar
• Yang G, Pan C, Lu J. Prevalence of erectile dysfunction among Chinese men with type 2 diabetes mellitus. Int J Impot Res. 2010;22(5):310.
   PubMed Web of Science ®Google Scholar
• Hassan A, Aburisheh K, Sheikh TJ, et al. Prevalence of erectile dysfunction among Saudi type 2 diabetic patients. Eur Rev Med Pharmacol Sci. 2014;18(7):1048–1057.
   PubMed Web of Science ®Google Scholar
• El Mahalli AA. Prevalence and predictors of depression among type 2 diabetes mellitus outpatients in Eastern Province, Saudi Arabia. Int J Health Sci (Qassim). 2015;9(2):119.
   PubMedGoogle Scholar
• Salinero-Fort MÁ, San Andrés-Rebollo FJ, de Burgos-lunar C, et al.. Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES study. PLoS One. 2013;8(10):e76417. DOI:10.1371/journal.pone.0076417.
   PubMed Web of Science ®Google Scholar
• Ji L, Lu J, Weng J, et al.. China type 2 diabetes treatment status survey of treatment pattern of oral drugs users. J Diabetes. 2015;7(2):166–173. DOI:10.1111/1753-0407.12165.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang J, Tao L, et al.. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China. BMJ open. 2017;7(9):e016280. DOI:10.1136/bmjopen-2017-016280.
   PubMed Web of Science ®Google Scholar
• Jin P, Peng J, Zou H, et al.. The 5-year onset and regression of diabetic retinopathy in Chinese type 2 diabetes patients. PLOS One. 2014;9(11):e113359. DOI:10.1371/journal.pone.0113359.
   PubMed Web of Science ®Google Scholar
• Lee KMC, Sum WMR. Prevalence of diabetic retinopathy in patients with recently diagnosed diabetes mellitus. Clin Exp Optometry. 2011;94(4):371–375.
   PubMed Web of Science ®Google Scholar
• Lyu Y, Luo Y, Li C, et al.. Regional differences in the prevalence of coronary heart disease and stroke in patients with type 2 diabetes in China. J Clin Endocrinol Metab. 103(9): 3319–3330. 2018. . doi:10.1210/jc.2018-00422.
   PubMed Web of Science ®Google Scholar
• Zou X, Zhou X, Ji L, et al. The characteristics of newly diagnosed adult early-onset diabetes: a population-based cross-sectional study. Sci Rep. 2017;7:46534.
   PubMed Web of Science ®Google Scholar
• Huo X, Zhang J, Guo X, et al. gender Difference in the association of early-vs. late-Onset Type 2 Diabetes with non-Fatal Microvascular Disease in china: a cross-sectional study. Front Endocrinol (Lausanne). 2018;9:15.
   PubMed Web of Science ®Google Scholar
• Liu Y, Song Y, Tao L, et al.. Prevalence of diabetic retinopathy among 13473 patients with diabetes mellitus in China: a cross-sectional epidemiological survey in six provinces. BMJ Open. 2017;7(1):e013199. DOI:10.1136/bmjopen-2016-013199.
   PubMed Web of Science ®Google Scholar
• Bamanie AH, Al-Noury KI. Prevalence of hearing loss among Saudi type 2 diabetic patients. Saudi Med J. 2011;32(3):271–274.
   PubMed Web of Science ®Google Scholar
• Albasheer OB, Mahfouz MS, Solan Y, et al.. Depression and related risk factors among patients with type 2 diabetes mellitus, Jazan area, KSA: A cross-sectional study. Diabetes Metab Syndr. 2018;12(2):117–121. DOI:10.1016/j.dsx.2017.09.014.
   PubMed Web of Science ®Google Scholar
• Schellini SA, Carvalho GMD, Rendeiro FS, et al.. Prevalence of diabetes and diabetic retinopathy in a Brazilian population. Ophthalmic Epidemiol. 2014;21(1):33–38. DOI:10.3109/09286586.2013.868004.
   PubMed Web of Science ®Google Scholar
• Nathoo N, Ng M, Rudnisky CJ, et al.. The prevalence of diabetic retinopathy as identified by teleophthalmology in rural Alberta. Cana J Ophthalmol. 2010;45(1):28–32. DOI:10.3129/i09-220.
   PubMed Web of Science ®Google Scholar
• Douros A, Dell’Aniello S, Yu OH, Filion KB, Azoulay L, Suissa S. Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study. BMJ. 2018;362:k2693.
   PubMed Web of Science ®Google Scholar
• Bringer J, Fontaine P, Detournay B, et al.. Prevalence of diagnosed type 2 diabetes mellitus in the French general population: the INSTANT study. Diabetes Metab. 2009;35(1):25–31. DOI:10.1016/j.diabet.2008.06.004.
   PubMed Web of Science ®Google Scholar
• Bramlage P, Gitt AK, Schneider S, et al.. Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up. BMC Cardiovasc Disord. 2014;14(1):162. DOI:10.1186/1471-2261-14-162.
   PubMed Web of Science ®Google Scholar
• Bramlage P, Binz C, Gitt AK, et al.. Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline. Cardiovasc Diabetol. 2010;9(1):53. DOI:10.1186/1475-2840-9-53.
   PubMed Web of Science ®Google Scholar
• Jacob L, Kostev K. Prevalence of depression in type 2 diabetes patients in German primary care practices. J Diabetes Complications. 2016;30(3):432–437.
   PubMed Web of Science ®Google Scholar
• De Cosmo S, Rossi MC, Pellegrini F, et al.. Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes. Nephrol Dialysis Transplantation. 2014;29(3):657–662. DOI:10.1093/ndt/gft506.
   PubMed Web of Science ®Google Scholar
• González-Clemente JM, Font B, Lahoz R, et al.. Inercia clínica en pacientes con diabetes mellitus tipo 2 no insulinizados en tratamiento con hipoglucemiantes orales. Estudio INERCIA. Medicina Clínica. 2014;142(11):478–484. DOI:10.1016/j.medcli.2013.02.032.
   PubMed Web of Science ®Google Scholar
• Conthe P, Mata M, Orozco D, et al.. Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain. Diabetes Res Clin Pract. 2011;91(1):108–114. DOI:10.1016/j.diabres.2010.10.002.
   PubMed Web of Science ®Google Scholar
• López M, Cos FX, Álvarez-Guisasola F, et al. Prevalence of diabetic retinopathy and its relationship with glomerular filtration rate and other risk factors in patients with type 2 diabetes mellitus in Spain. DM2 HOPE study. J Clin Transl Endocrinol. 2017;9:61–65.
   PubMedGoogle Scholar
• Barrot‐de la Puente J, Mata-Cases M, Franch-Nadal J, et al.. Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database. Int J Clin Pract. 2015;69(12):14861495. DOI:10.1111/ijcp.12741.
   Web of Science ®Google Scholar
• Cols-Sagarra C, López-Simarro F, Alonso-Fernández M, et al.. Prevalence of depression in patients with type 2 diabetes attended in primary care in Spain. Prim Care Diabetes. 2016;10(5):369–375. DOI:10.1016/j.pcd.2016.02.003.
   PubMed Web of Science ®Google Scholar
• Collier A, Ghosh S, Hair M, et al.. Gender differences and patterns of cardiovascular risk factors in Type 1 and Type 2 diabetes: a population-based analysis from a Scottish region. Diabet Med. 2015;32(1):42–46. DOI:10.1111/dme.12569.
   PubMed Web of Science ®Google Scholar
• Sivaprasad S, Gupta B, Gulliford MC, et al.. Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK). PloS one. 2012;7(3):e32182. DOI:10.1371/journal.pone.0032182.
   PubMed Web of Science ®Google Scholar
• Thomas RL, Dunstan F, Luzio SD, et al.. Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. BMJ. 2012;344(feb22 1):e874. DOI:10.1136/bmj.e874.
   PubMed Web of Science ®Google Scholar
• Martín-Merino E, Fortuny J, Rivero-Ferrer E, et al.. Incidence of retinal complications in a cohort of newly diagnosed diabetic patients. PLOS One. 2014;9(6):e100283. DOI:10.1371/journal.pone.0100283.
   PubMed Web of Science ®Google Scholar
• Jones CD, Greenwood RH, Misra A, et al.. Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care. 2012;35(3):592–596. DOI:10.2337/dc11-0943.
   PubMed Web of Science ®Google Scholar
• Thomas RL, Dunstan FD, Luzio SD, et al.. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service. Br J Ophthalmol. 2015;99(1):64–68. DOI:10.1136/bjophthalmol-2013-304017.
   PubMed Web of Science ®Google Scholar
• Dedov I, Maslova O, Suntsov Y, Bolotskaia L, Milenkaia T, Besmertnaia L. Prevalence of diabetic retinopathy and cataract in adult patients with type 1 and type 2 diabetes in Russia. The Rev Diabetic Studies: RDS. 2009;6(2):124. DOI:10.1900/RDS.2009.6.124.
   PubMedGoogle Scholar
• Al-Zamil WM. Hospital Prevalence of Retinopathy in Patients with Newly-Diagnosed Type 2 Diabetes. Saudi J Med Med Sci. 2017;5(1):26–30.
   PubMed Web of Science ®Google Scholar
• Pham I, Cosson E, Nguyen MT, et al. Evidence for a Specific Diabetic Cardiomyopathy: An Observational Retrospective Echocardiographic Study in 656 Asymptomatic Type 2 Diabetic Patients. Int J Endocrinol. 2015;2015:8.
   Web of Science ®Google Scholar
• Pedro R-A, Ramon S-A, Marc -B-B, et al.. Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the North-East of Spain, a population-based study. Ophthalmic Epidemiol. 2010;17(4):251–265. DOI:10.3109/09286586.2010.498661.
   PubMed Web of Science ®Google Scholar
• Baba M, Davis WA, Norman PE, et al. Temporal changes in the prevalence and associates of diabetes-related lower extremity amputations in patients with type 2 diabetes: the Fremantle Diabetes Study. Cardiovasc Diabetol. 2015;14:152.
   PubMed Web of Science ®Google Scholar
• Kontopantelis E, Springate DA, Reeves D, et al.. Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study. Diabetologia. 2015;58(3):505–518. DOI:10.1007/s00125-014-3473-8.
   PubMed Web of Science ®Google Scholar
• Lee KM, Sum WM. Prevalence of diabetic retinopathy in patients with recently diagnosed diabetes mellitus. Clin Exp Optom. 2011;94(4):371–375.
   PubMed Web of Science ®Google Scholar
• Hammes H-P, Welp R, Kempe H-P, et al.. Risk Factors for Retinopathy and DME in Type 2 Diabetes—Results from the German/Austrian DPV Database. PLOS One. 2015;10(7):e0132492. DOI:10.1371/journal.pone.0132492.
   PubMed Web of Science ®Google Scholar
• Kramer CK, Rodrigues TC, Canani LH, et al.. Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies. Diabetes Care. 2011;34(5):1238–1244. DOI:10.2337/dc11-0079.
   PubMed Web of Science ®Google Scholar
• Charbonnel B, Simon D, Dallongeville J, et al.. Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis. Pharmacoecon Open. 2018;2(2):209–219. DOI:10.1007/s41669-017-0050-3.
   PubMed Web of Science ®Google Scholar
• López M, Cos FX, Álvarez-Guisasola F, et al. Prevalence of diabetic retinopathy and its relationship with glomerular filtration rate and other risk factors in patients with type 2 diabetes mellitus in Spain. DM2 HOPE study. J Clin Transl Endocrinol. 2017;9:61–65.
   PubMedGoogle Scholar
• Parisi MCR, Moura Neto A, Menezes FH, et al.. Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study. Diabetol Metab Syndr. 2016;8(1):25. DOI:10.1186/s13098-016-0126-8.
   PubMed Web of Science ®Google Scholar
• Van Buren PN, Toto R. Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis. 2011;18(1):28–41.
   PubMed Web of Science ®Google Scholar
• Ku E, Lee BJ, Wei J, et al.. Hypertension in CKD: core curriculum 2019. Am J Kidney Diseases. 2019;74(1):120–131. DOI:10.1053/j.ajkd.2018.12.044.
   PubMed Web of Science ®Google Scholar
• Gong Q, Zhang P, Wang J, et al.. Changes in mortality in people with IGT before and after the onset of diabetes during the 23-year follow-up of the Da Qing Diabetes Prevention Study. Diabetes Care. 2016;39(9):1550–1555. DOI:10.2337/dc16-0429.
   PubMed Web of Science ®Google Scholar
• Wu D, Xuan Y, Ruan Y, et al.. Prevalence of macro-and microvascular complications in patients with type 2 diabetes and kidney disease with or without albuminuria in a single Chinese Diabetes Centre. Diab Vasc Dis Res. 2016;13(1):21–30. DOI:10.1177/1479164115610247.
   PubMed Web of Science ®Google Scholar
• Hadjadj S, Cariou B, Fumeron F, et al.. Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes. Diabetologia. 2016;59(1):208–216. DOI:10.1007/s00125-015-3785-3.
   PubMed Web of Science ®Google Scholar
• Cea Soriano L, Johansson S, Stefansson B, et al.. Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors. Cardiovasc Diabetol. 2015;14(1):38. DOI:10.1186/s12933-015-0204-5.
   PubMed Web of Science ®Google Scholar
• Khan AR, Al Abdul Lateef ZN, Fatima S, et al.. Prevalence of chronic complication among type 2 diabetics attending primary health care centers of Al Ahsa district of Saudi Arabia: a cross sectional survey. Glob J Health Sci. 2014;6(4):245–253. DOI:10.5539/gjhs.v6n4p245.
   PubMedGoogle Scholar
• Balkau B, Halimi S, Blickle J-F, et al.. Reasons for non-intensification of treatment in people with type 2 diabetes receiving oral monotherapy: Outcomes from the prospective DIAttitude study. Ann Endocrinol. 2016;77(6):649–657. Elsevier. doi:10.1016/j.ando.2016.03.001.
   PubMed Web of Science ®Google Scholar
• Chuang YC, Chung M-S, Wang P-W, et al.. Albuminuria is an independent risk factor of erectile dysfunction in men with type 2 diabetes. J Sex Med. 2012;9(4):1055–1064. DOI:10.1111/j.1743-6109.2011.02586.x.
   PubMed Web of Science ®Google Scholar
• Alzahrani HA, Wang D, Bakhotmah BA, et al.. Risk factors for peripheral artery disease among patients with diabetes in Saudi Arabia. Vasc Med (United Kingdom). 2014;19(2):103–111. DOI:10.1177/1358863X14526948.
   Web of Science ®Google Scholar
• Duan JG, Chen XY, Wang L, et al.. Sex differences in epidemiology and risk factors of acute coronary syndrome in Chinese patients with type 2 diabetes: A long-term prospective cohort study. PLOS One. 2015;10(4):e0122031. DOI:10.1371/journal.pone.0122031.
   PubMed Web of Science ®Google Scholar
• Hu WS, Lin CL. Use of the progression of adapted Diabetes Complications Severity Index to predict acute coronary syndrome, ischemic stroke, and mortality in Asian patients with type 2 diabetes mellitus: A nationwide cohort investigation. Clin Cardiol. 2018;41(8):1038–1043.
   PubMed Web of Science ®Google Scholar
• Yan BP, Zhang Y, Kong AP, et al.. Borderline ankle-brachial index is associated with increased prevalence of micro- and macrovascular complications in type 2 diabetes: A cross-sectional analysis of 12,772 patients from the Joint Asia Diabetes Evaluation Program. Diab Vasc Dis Res. 2015;12(5):334–341. DOI:10.1177/1479164115590559.
   PubMed Web of Science ®Google Scholar
• Degli Esposti L, Di Martino M, Saragoni S, et al.. Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases. Clinicon Econ Outcomes Res. 2013;5(2):193. DOI:10.1586/14737167.5.2.193.
   PubMedGoogle Scholar
• Henriques RS, Steimbach LM, Baptista DR, et al.. Direct costs of type 2 diabetes: a Brazilian cost-of-illness study. Int J Technol Assess Health Care. 2018;34(2):180–188. DOI:10.1017/S026646231800017X.
   PubMed Web of Science ®Google Scholar
• Li X, Xu Z, Weng J. Direct medical costs of type 2 diabetes in China: a multicentre, prospective cohort study. Lancet Diabetes Endocrinol. 2016;4:S5.
   PubMed Web of Science ®Google Scholar
• Bruno G, Picariello R, Petrelli A, et al.. Direct costs in diabetic and non diabetic people: the population-based Turin study, Italy. Nutr Metab Cardiovasc Dis. 2012;22(8):684–690. DOI:10.1016/j.numecd.2011.04.007.
   PubMed Web of Science ®Google Scholar
• Wu H, Eggleston KN, Zhong J, et al.. Direct medical cost of diabetes in rural China using electronic insurance claims data and diabetes management data. J Diabetes Investig. 2019;10(2):531–538. DOI:10.1111/jdi.12897.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Wu EQ, Xie K, et al.. PDB40 Economic Burden of Type 2 Diabetes Mellitus in China. Value Health. 2012;15(4):A177. DOI:10.1016/j.jval.2012.03.961.
   Web of Science ®Google Scholar
• Nuno-Solinis R, Alonso-Morán E, Arteagoitia Axpe JM, et al.. Healthcare costs of people with type 2 diabetes mellitus in the Basque Country (Spain). Endocrinol Nutr. 2016;63(10):543–550. DOI:10.1016/j.endonu.2016.08.003.
   PubMedGoogle Scholar
• Von Lengerke T, Hagenmeyer E-G, Gothe H, et al.. Excess health care costs of obesity in adults with diabetes mellitus: a claims data analysis. Exp Clin Endocrinol Diabetes. 2010;118(8):496–504. DOI:10.1055/s-0030-1253400.
   PubMed Web of Science ®Google Scholar
• Mata-Cases M, Casajuana M, Franch-Nadal J, et al.. Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain. Eur J Health Econ. 2016;17(8):1001–1010. DOI:10.1007/s10198-015-0742-5.
   PubMed Web of Science ®Google Scholar
• Almutairi N, Alkharfy KM. Direct medical cost and glycemic control in type 2 diabetic Saudi patients. Appl Health Econ Health Policy. 2013;11(6):671–675.
   PubMedGoogle Scholar
• Jacobs E, Hoyer A, Brinks R, et al.. Healthcare costs of Type 2 diabetes in Germany. Diabet Med. 2017;34(6):855–861. DOI:10.1111/dme.13336.
   PubMed Web of Science ®Google Scholar
• Saad R, Piedade A, Wiens A, et al.. Hospitalization Costs of Type 2 Diabetes Mellitus (T2dm) Patients In A Public Hospital In Brazil. Value Health. 2015;18(7):A809. DOI:10.1016/j.jval.2015.09.095.
   Web of Science ®Google Scholar
• Bahia LR, Araujo DV, Schaan BD, et al.. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system. Value Health. 2011;14(5):S137–S140. DOI:10.1016/j.jval.2011.05.009.
   PubMed Web of Science ®Google Scholar
• Li W, Zhang Y, Tang JL, Guo XH, Lou QQ, Sun ZL.  Self-management obedience rate, metabolic control and cost of diabetes associated with medical insurance in China. Diabetologia. 2016 Aug 1 (Vol. 59, pp. S396-S397) SPRINGER 233 SPRING ST, NEW YORK, NY 10013 USA
   Web of Science ®Google Scholar
• Kumar M, Gupta S, Liu G, et al.. Demographics And Health Outcomes Associated With Adherence And Non-Adherence Among Type2 Diabetcics In China. Value Health. 2014;17(7):A746. DOI:10.1016/j.jval.2014.08.169.
   PubMed Web of Science ®Google Scholar
• Li H, Chen B, Shah N, et al.. Socioeconomic correlates of inpatient spending for patients with type 2 diabetes mellitus in China: evidence from Hangzhou. Exp Clin Endocrinol Diabetes. 2012;120(1):35–44. DOI:10.1055/s-0031-1291178.
   PubMed Web of Science ®Google Scholar
• Wang H, Lin X, Zhang Z, et al.. The economic burden of inpatients with type 2 diabetes: a case study in a Chinese hospital. Asia Pac J Public Health. 2015;27(2_suppl):49S54S. DOI:10.1177/1010539515572220.
   Web of Science ®Google Scholar
• Bao X, Yang C, Fang K, et al.. Hospitalization costs and complications in hospitalized patients with type 2 diabetes mellitus in Beijing, China: 中国北京市 2 型糖尿病住院患者费用与并发症的关系分析. J Diabetes. 9(4): 405–411. 2017. . doi:10.1111/1753-0407.12428.
   PubMed Web of Science ®Google Scholar
• Long Q, He M, Tang X, et al.. Treatment of Type 2 diabetes mellitus in Chongqing of China: unaffordable care for the poor. Diabetic Med. 2017;34(1):120–126. DOI:10.1111/dme.13193.
   PubMed Web of Science ®Google Scholar
• Wong CK, Jiao F, Tang EHM, et al.. Direct medical costs of diabetes mellitus in the year of mortality and year preceding the year of mortality. Diabetes Obesity Metab. 2018;20(6):1470–1478. DOI:10.1111/dom.13253.
   PubMed Web of Science ®Google Scholar
• Cheng S-H, Chen -C-C, Tseng C-H. Does medication adherence lead to lower healthcare expenses for patients with diabetes?. Am J Manag Care. 2013;19(8):662–670.
   PubMed Web of Science ®Google Scholar
• Sapozhnikova I, Tarlovskaya E, Avksentyeva M. Typical management practice in outpatients with type 2 diabetes mellitus in cities, towns, and villages. Terapevticheskii arkhiv. 2016;88(1):75–81.
   PubMed Web of Science ®Google Scholar
• Keskek SO, Kirim S, Yanmaz N. Estimated costs of the treatment of diabetic foot ulcers in a tertiary hospital in Turkey. Pak J Med Sci. 2014;30(5):968.
   PubMed Web of Science ®Google Scholar
• Gentil L, Vasiliadis H-M, Préville M, et al.. Adherence to Oral Antihyperglycemic Agents Among Older Adults With Mental Disorders and Its Effect on Health Care Costs, Quebec, Canada, 2005-2008. Prev Chronic Dis. 2015;12(p):E230–E230. DOI:10.5888/pcd12.150412.
   PubMed Web of Science ®Google Scholar
• Ricci P, Blotière PO, Weill A, Simon D, Tuppin P, Ricordeau P, Allemand H. Diabète traité: quelles évolutions entre 2000 et 2009 en France. Bull Epidemiol Hebd. 2010;42(43):425–431.
   Google Scholar
• Sittig DT, Friedel H, Wasem J. Prevalence and treatment costs of type 2 diabetes in Germany and the effects of social and demographical differences. Eur J Health Econ. 2015;16(3):305–311.
   PubMed Web of Science ®Google Scholar
• Müller N, Heller T, Freitag MH, et al.. Healthcare utilization of people with type 2 diabetes in Germany: an analysis based on health insurance data. Diabetic Med. 2015;32(7):951–957. DOI:10.1111/dme.12747.
   PubMed Web of Science ®Google Scholar
• Kahm K, Laxy M, Schneider U, et al.. Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany. Diabetes Care. 41(5): 971–978. 2018. . doi:10.2337/dc17-1763.
   PubMed Web of Science ®Google Scholar
• Bruno G, Karaghiosoff L, Merletti F, et al.. The impact of diabetes on prescription drug costs: the population-based Turin study. Diabetologia. 2008;51(5):795–801. DOI:10.1007/s00125-008-0957-4.
   PubMed Web of Science ®Google Scholar
• Demurtas J, Alba N, Rigon G, Nesoti MV, Bovo C, Vaona A. Epidemiological trends and direct costs of diabetes in a northern Italy area: 2012 health administrative records analysis LHT n. 20 Verona. Prim Care Diabetes. 2012;344(feb22 1):570–576. DOI:10.1016/j.pcd.2017.06.001.
   Web of Science ®Google Scholar
• Sicras-Mainar A, Font-Ramos B, Roldán-Suárez C, et al.. [Characterization of and costs associated to the profile of patients with type 2 diabetes treated with metformin who are added a second oral antidiabetic drug: a population study]. Endocrinol Nutr. 2013;60(10):557–569. DOI:10.1016/j.endonu.2013.04.011.
   PubMedGoogle Scholar
• Sicras-Mainar A, Rejas-Gutiérrez J, Navarro-Artieda R, et al.. Effect of smoking status on healthcare costs and resource utilization in patients with type 2 diabetes in routine clinical practice: a retrospective nested case-control economic study. Eur Addict Res. 2014;20(2):94–104. DOI:10.1159/000355171.
   PubMed Web of Science ®Google Scholar
• Currie CJ, Poole CD, Woehl A, et al.. The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabet Med. 2007;24(2):187–194. DOI:10.1111/j.1464-5491.2006.02057.x.
   PubMed Web of Science ®Google Scholar
• Morgan CL, Peters JR, Dixon S, et al.. Estimated costs of acute hospital care for people with diabetes in the United Kingdom: a routine record linkage study in a large region. Diabet Med. 27(9): 1066–1073. 2010. . doi:10.1111/j.1464-5491.2010.03086.x.
   PubMed Web of Science ®Google Scholar
• Govan L, Wu O, Briggs A, et al.. Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia. 2011;54(8):2000–2008. DOI:10.1007/s00125-011-2176-7.
   PubMed Web of Science ®Google Scholar
• Borges NB, Ferraz MB, Chacra AR. The cost of type 2 diabetes in Brazil: evaluation of a diabetes care center in the city of São Paulo, Brazil. Diabetol Metab Syndr. 2014;6(1):122.
   PubMed Web of Science ®Google Scholar
• Le C, Lin L, Jun D, et al.. The economic burden of type 2 diabetes mellitus in rural southwest China. Int J Cardiol. 2013;165(2):273–277. DOI:10.1016/j.ijcard.2011.08.039.
   PubMed Web of Science ®Google Scholar
• Ulrich S, Holle R, Wacker M, Stark R, Icks A, Thorand B, Peters A, Laxy M. Cost burden of type 2 diabetes in Germany: results from the population-based KORA studies. BMJ Open. 6(11): e012527. 2016. . doi:10.1136/bmjopen-2016-012527.
   PubMed Web of Science ®Google Scholar
• Bouee S, Cochinaire A, Godard C, et al.. Real World Incidence of Type 2 Diabetes (T2D) Complications Leading to Hospitalization in France: The Recode Study. Value Health. 2013;16(7):A434. DOI:10.1016/j.jval.2013.08.637.
   PubMed Web of Science ®Google Scholar
• McMeekin P, Geue C, Wu O, Mocevic E, Hoxer CS, Ochs A, McGurnaghan S, Colhoun H. Costs of prevalent and incident cardiovascular disease in patients with type 2 diabetes in Scotland using routinely collected data. Diabetologia. 2018 Oct 1;Vol. 61, p. S115–S115; SPRINGER 233 SPRING ST, NEW YORK, NY 10013 USA
   Web of Science ®Google Scholar
• Yang C, Huang Z, Sun K, et al. Comparing the Economic Burden of Type 2 Diabetes Mellitus Patients with and without Medical Insurance: A Cross-Sectional Study in China. Med Sci Monit. 2018;24:3098.
   PubMed Web of Science ®Google Scholar
• Duan X, Li Y, Liu Q, Liu L, Li C. Epidemiological characteristics, medical costs and healthcare resource utilization of diabetes-related complications among Chinese patients with type 2 diabetes mellitus. Expert Rev Pharmacoecon Outcomes Res. 2019.
   Web of Science ®Google Scholar
• Morsanutto A, Berto P, Lopatriello S, et al.. Major complications have an impact on total annual medical cost of diabetes: results of a database analysis. J Diabetes Complications. 2006;20(3):163–169. DOI:10.1016/j.jdiacomp.2005.06.011.
   PubMed Web of Science ®Google Scholar
• Wang W, Fu CW, Pan CY, et al.. How do type 2 diabetes mellitus‐related chronic complications impact direct medical cost in four major cities of urban China?. Value Health. 12(6): 923–929. 2009. . doi:10.1111/j.1524-4733.2009.00561.x.
   PubMed Web of Science ®Google Scholar
• Liu Q, Chen Y, Chu Y. Direct Medical Cost and Healthcare Resource Utilization in Elderly Patients with Type 2 Diabetes Mellitus Among Insured Urban Population in China. Value Health. 2016;19(7):A670.
   PubMed Web of Science ®Google Scholar
• Cao P, Wang K, Zhang H, et al.. Factors influencing the hospitalization costs of patients with type 2 diabetes. Asia Pac J Public Health. 2015;27(2_suppl):55S60S. DOI:10.1177/1010539515573831.
   Web of Science ®Google Scholar
• Chen D, Liu S, Tan X, et al. Assessment of hospital length of stay and direct costs of type 2 diabetes in Hubei Province, China. BMC Health Serv Res. 2017;17(1):199. DOI:10.1186/s12913-017-2140-4.
   PubMed Web of Science ®Google Scholar
• Chen H-L, Hsu WW-Y, Hsiao F-Y. Changes in prevalence of diabetic complications and associated healthcare costs during a 10-year follow-up period among a nationwide diabetic cohort. J Diabetes Complications. 2015;29(4):523–528.
   PubMed Web of Science ®Google Scholar
• Satman I, Akalin S, Ozdemir O. PDB27 The Relationship Between the Presence of Metabolic Complications and Cost Components of Type 2 Diabetes Mellitus Patients in Turkey. Value Health. 2012;15(7):A498.
   Web of Science ®Google Scholar
• Akalin S, Satman I, Ozdemir O. PDB28 Cost of Disease and its Relationship With Diabetic Complications in Turkish Patients With Type 2 Diabetes Mellitus. Value Health. 2012;15(7):A498.
   Web of Science ®Google Scholar
• Bao X, Yang C, Fang K, et al.. Hospitalization costs and complications in hospitalized patients with type 2 diabetes mellitus in Beijing, China. J Diabetes. 2017;9(4):405–411.
   PubMed Web of Science ®Google Scholar
• Chan B, Tsang MW, Lee VWY, et al.. Cost of Type 2 Diabetes mellitus in Hong Kong Chinese. Int J Clin Pharmacol Ther. 2007;45(8):455–468. DOI:10.5414/CPP45455.
   PubMed Web of Science ®Google Scholar
• Sancho-Mestre C, Vivas-Consuelo D, Alvis-Estrada L, et al.. Pharmaceutical cost and multimorbidity with type 2 diabetes mellitus using electronic health record data. BMC Health Serv Res. 2016;16(1):394. DOI:10.1186/s12913-016-1649-2.
   PubMed Web of Science ®Google Scholar
• Guelfucci F, Clay E, Aballéa S, et al.. Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France. BMC Endocr Disord. 2013;13(1):15. DOI:10.1186/1472-6823-13-15.
   PubMed Web of Science ®Google Scholar
• Alonso-Morán E, Orueta JF, Nuño-Solinís R. Incidence of severe hypoglycaemic episodes in patients with type 2 diabetes in the Basque country: impact on healthcare costs. BMC Health Serv Res. 2015;15(1):207.
   PubMed Web of Science ®Google Scholar
• Veronese G, Marchesini G, Forlani G, et al.. Costs associated with emergency care and hospitalization for severe hypoglycemia. Nutr Metab Cardiovasc Dis. 2016;26(4):345–351. DOI:10.1016/j.numecd.2016.01.007.
   PubMed Web of Science ®Google Scholar
• Giorda CB, Rossi MC, Ozzello O, Gentile S, Aglialoro A, Chiambretti A, Baccetti F, Gentile FM, Romeo F, Lucisano G, Nicolucci A. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study. Nutrition. Metab Cardiovasc Dis. 2017;27(3):209–216. DOI:10.1016/j.numecd.2016.10.005.
   PubMed Web of Science ®Google Scholar
• Lachaine J, Beauchemin C, Flavin J. PDB42 Health Care Resources Utilization and Cost for Hypoglycemia and Metabolic Acidosis in Type Ii Diabetes: an Analysis of the Ramq Database. Value Health. 2012;15(4):A178.
   Web of Science ®Google Scholar
• Alexiu CJ, Chuck A, Jelinski SE, Rowe BH. Presentations for hypoglycemia associated with diabetes mellitus to emergency departments in a Canadian province: A database and epidemiological analysis. Diabetes Res Clin Pract. 2017;130:229–236.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Wu J, Österle A. PDB61 Research on the Incidence and Cost of Hypoglycemia Episode in Patients With Type 2 Diabetes Mellitus (T2DM). Value Health. 2012;15(7):A504–A505.
   PubMed Web of Science ®Google Scholar
• Zhong G-C, Ye M-X, Cheng J-H, et al. HbA 1c and Risks of All-Cause and Cause-Specific Death in Subjects without Known Diabetes: A Dose-Response Meta-Analysis of Prospective Cohort Studies. Sci Rep. 2016;6:24071.
   PubMed Web of Science ®Google Scholar
• Constantino MI, Molyneaux L, Limacher-Gisler F, et al.. Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care. 2013;36(12):3863–3869. DOI:10.2337/dc12-2455.
   PubMed Web of Science ®Google Scholar
• Owolabi MO, Yaria JO, Daivadanam M, et al.. Gaps in guidelines for the management of diabetes in low-and middle-income versus high-income countries—a systematic review. Diabetes Care. 2018;41(5):1097–1105. DOI:10.2337/dc17-1795.
   PubMed Web of Science ®Google Scholar
• Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. PharmacoEcon. 2015;33(8):811–831.
   PubMed Web of Science ®Google Scholar
• Moucheraud C, Lenz C, Latkovic M, et al.. The costs of diabetes treatment in low-and middle-income countries: a systematic review. BMJ Glob Health. 2019;4(1):e001258. DOI:10.1136/bmjgh-2018-001258.
   PubMed Web of Science ®Google Scholar
• Einarson TR, Acs A, Ludwig C, et al.. Economic burden of cardiovascular disease in type 2 diabetes: a systematic review. Value Health. 2018;21(7):881–890. DOI:10.1016/j.jval.2017.12.019.
   PubMed Web of Science ®Google Scholar
• Arnold SV, Lipska KJ, Wang J, et al.. Use of intensive glycemic management in older adults with diabetes mellitus. J Am Geriatr Soc. 2018;66(6):1190–1194. DOI:10.1111/jgs.15335.
   PubMed Web of Science ®Google Scholar
• Mahoney GK, Henk HJ, McCoy RG. Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes: Population-Based Modeling Study, 2011-2014. Mayo Clin Proc. 2019;94(9):1731–1742. Elsevier. DOI:10.1016/j.mayocp.2019.02.028.
   PubMed Web of Science ®Google Scholar
• Riddle MC, Herman WH. The cost of diabetes care—an elephant in the room. Diabetes Care. 2018;41(5):929–932.
   PubMed Web of Science ®Google Scholar
• Mohan V, Cooper ME, Matthews DR, et al.. Management of Type 2 Diabetes in Developing Countries: Balancing Optimal Glycaemic Control and Outcomes with Affordability and Accessibility to Treatment. Diabetes Therapy. 10(S1): 1–21. 2019 . DOI:10.1007/s13300-019-0573-y.
   PubMed Web of Science ®Google Scholar
• Duarte AA, Mohsin S, Golubnitschaja O. Diabetes care in figures: current pitfalls and future scenario. EPMA Journal. 2018;9(2):125–131.
   PubMed Web of Science ®Google Scholar
• Ng CS, Lee JYC, Toh MP, et al.. Cost-of-illness studies of diabetes mellitus: a systematic review. Diabetes Res Clin Pract. 2014;105(2):151–163. DOI:10.1016/j.diabres.2014.03.020.
   PubMed Web of Science ®Google Scholar
• Khunti K, Seidu S, Kunutsor S, et al.. Association Between Adherence to Pharmacotherapy and Outcomes in Type 2 Diabetes: A Meta-analysis. Diabetes Care. 2017;40(11):1588–1596. DOI:10.2337/dc16-1925.
   PubMed Web of Science ®Google Scholar